天天操精品视频-天天操精品-天天操狠狠干-天天操狠狠操-国产乱码精品一区二区三区四川-国产乱码精品一区二区三

海西新藥遞表港交所 聯席保薦人為華泰國際和招銀國際
來源：證券時報網作者：李志強2025-08-07 07:54

海西新藥向港交所提交上市申請，聯席保薦人為華泰國際和招銀國際。

公司采用“雙軌模式”，涵蓋仿制藥和在研創新藥。已獲得14款仿制藥的NMPA批準，并有四款在研創新藥，包括一款潛在同類首創的腫瘤藥物和一款潛在首款口服wAMD/DME/RVO藥物。

商業化產品組合主要針對消化系統、心血管系統、內分泌系統、神經系統和炎癥疾病，這些領域占2023年中國醫藥銷售總額的25%以上。公司客戶主要為國有醫藥分銷公司、藥店及零售商。

責任編輯： 孫孝熙
校對： 廖勝超
海西新藥
上市申請
華泰國際
聲明：證券時報力求信息真實、準確，文章提及內容僅供參考，不構成實質性投資建議，據此操作風險自擔
下載“證券時報”官方APP，或關注官方微信公眾號，即可隨時了解股市動態，洞察政策信息，把握財富機會。
網友評論
登錄后可以發言
發送
網友評論僅供其表達個人看法，并不表明證券時報立場
暫無評論
為你推薦
時報熱榜
換一換
    熱點視頻
    換一換
    主站蜘蛛池模板： | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |